Physician profile

Jamie M Bartley

Urology · Farmington Hills, MI

NPI 1629286463

$11,349.28

in general payments reported to CMS, 2019-2025

46 companies · $910 in 2025

The $910 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,771.73
Travel and Lodging$943.11
Consulting Fee$800.00
Honoraria$241.16

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Axonics, INC. $3,721.68 2020-2024 Bulkamid, Axonics
Boston Scientific Corporation $2,369.35 2019-2025 Axonics
Medtronic, INC. $2,236.50 2021-2025 Interstim, Altaviva
Coloplast Corp $336.86 2019-2025 Speedicath, Porges Coloplast
Astellas Pharma US INC $298.41 2019-2022
Caldera Medical, INC $290.72 2022-2024 Desara
Calyxo, INC. $225.51 2025 Cvac Aspiration System
Abbvie INC. $225.23 2021-2025 Botox
Medtronic USA, INC. $152.81 2019-2020
Janssen Biotech, INC. $149.09 2020-2024 Erleada, Akeega
Procept Biorobotics Corporation $133.24 2019
Janssen Scientific Affairs, LLC $128.26 2019-2025
Amgen INC. $97.52 2019-2023 Xgeva
Olympus America INC. $97.11 2024 Itind System
Teleflex LLC $95.08 2025 Barrigel
Show all 46 companies
CompanyGeneral paymentsYearsTop products
Urogen Pharma, INC. $56.60 2022-2025
Tolmar, INC. $52.73 2023
Antares Pharma, INC. $52.25 2021-2022
Davol INC. $47.62 2024 Arista Ah Flexitip
Dendreon Pharmaceuticals LLC $45.02 2021-2022
Femselect INC. $41.20 2023 Enplace
Sumitomo Pharma America, INC. $32.40 2023-2024 Gemtesa
Allergan, INC. $27.50 2019-2021
Laborie Medical Technologies Corp. $27.31 2023
Telix Pharmaceuticals $25.29 2022
Cycle Pharmaceuticals INC $25.06 2025 Venxxiva
Myovant Sciences INC. $24.62 2022
Ferring Pharmaceuticals INC. $24.13 2024 Adstiladrin
Millicent US INC $23.94 2025 Femring, Intrarosa
Agiliti Surgical, INC. $23.42 2023 Bk3000, Bk3500 & Bk5000 Ultrasound System, Sonablate
Merck Sharp & Dohme LLC $21.94 2020
Bayer Healthcare Pharmaceuticals INC. $19.62 2023
Myriad Genetic Laboratories, INC. $19.50 2024 Prolaris
Endo Pharmaceuticals INC. $19.45 2020
Alexion Pharmaceuticals, INC. $19.15 2021
Convatec INC. $18.60 2023
Astrazeneca Pharmaceuticals LP $17.03 2022
Cook Medical LLC $16.88 2021
Integra Lifesciences Corporation $16.57 2021
Smith+Nephew, INC. $15.59 2024 Stravix Pl
Kowa Pharmaceuticals America, INC. $14.60 2022
Avation Medical, INC. $14.34 2025 Vivally System
Clarus Therapeutics INC. $14.24 2021
Coopersurgical, INC. $13.41 2021
Amag Pharmaceuticals, INC. $12.14 2019
Travere Therapeutics, INC. $9.76 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jamie M Bartley

$11,349.28

in general payments reported 2019-2025

Years
2019-2025
Top company
Axonics, INC.
Context
The $910 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/73802/jamie-m-bartley

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.